Back

American Psychiatric Association

  • Magnetic Resonance Imaging
  • Stress Disorders, Post-Traumatic
  • Transcranial Magnetic Stimulation

AJP CME: May 2026 – Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial

Transcranial magnetic stimulation (TMS) has shown promise in reducing posttraumatic stress disorder (PTSD) symptoms, with varied clinical results. A mechanistic understanding is needed to personalize treatment and improve response rates. The threat neurocircuitry, specifically the right amygdala, has consistently been implicated in PTSD pathophysiology. This neuroscience-informed trial aimed to modulate the threat neurocircuitry using functional MRI (fMRI) guided TMS to treat PTSD.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Journal-based
  • Credit · Up to 1 credit
  • Released
    May 1, 2026
  • Last day to claim credit
    May 1, 2028 2 years left